Dataset Information


PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.

ABSTRACT: In multiple types of tumors, fibrotic collagen is regarded as the 'highway' for cancer cell migration, which is mainly modified by lysyl hydroxylase 2 (PLOD2). The previous findings have demonstrated that the expression of PLOD2 was regulated by multiple factors, including HIF-1?, TGF-? and microRNA-26a/b. Although PLOD2 was confirmed to be related to poor prognosis in lung adenocarcinoma, the regulatory mechanism and function of PLOD2 in human lung adenocarcinoma is poorly understood. On the other hand, upregulation or hyperactivation of epidermal growth factor receptor is considered as a prognostic marker in many cancers, especially in non-small-cell lung cancer (NSCLC). In this study, we found that PLOD2 was elevated in NSCLC specimens and positively links to NSCLC poor prognosis. Gain- and loss-of-function studies and orthotopic implantation metastasis model pinpointed that PLOD2 promotes NSCLC metastasis directly by enhancing migration and indirectly by inducing collagen reorganization. In addition, we revealed that PLOD2 was regulated by PI3K/AKT-FOXA1 axis. The transcription factor FOXA1 directly bound to the PLOD2 promoter, and turned on PLOD2 transcription. In summary, our findings revealed a regulatory mechanism of NSCLC metastasis through EGFR-PI3K/AKT-FOXA1-PLOD2 pathway, and provided PLOD2 as a therapeutic target for NSCLC treatment.


PROVIDER: S-EPMC5680920 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5522040 | BioStudies
1000-01-01 | S-EPMC5427545 | BioStudies
2018-01-01 | S-EPMC6299564 | BioStudies
2019-01-01 | S-EPMC6554964 | BioStudies
2013-01-01 | S-EPMC3822914 | BioStudies
2019-01-01 | S-EPMC6727644 | BioStudies
1000-01-01 | S-EPMC5802325 | BioStudies
2018-01-01 | S-EPMC5809401 | BioStudies
2020-01-01 | S-EPMC6997870 | BioStudies
2009-01-01 | S-EPMC2659802 | BioStudies